tiprankstipranks
Genmab A/S (DE:GE9)
BERLIN:GE9

Genmab A/S (GE9) Technical Analysis

6 Followers

Summary of all the Indicators

Overall Consensus
Buy
11Bullish
2Neutral
8Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
4Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Genmab A/S’s (GE9) Moving Averages Convergence Divergence (MACD) indicator is -0.15, suggesting Genmab A/S is a Sell.
Genmab A/S’s (GE9) 20-Day exponential moving average is 243.57, while Genmab A/S’s (GE9) share price is €253, making it a Buy.
Genmab A/S’s (GE9) 50-Day exponential moving average is 249.39, while Genmab A/S’s (GE9) share price is €253, making it a Buy.

Genmab A/S (GE9) Pivot Points

Jul 22, 2024, 10:35 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
241.93
243.37
246.13
247.57
250.33
251.77
254.53
Fibonacci
243.37
244.97
245.96
247.57
249.17
250.16
251.77
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Genmab A/S (GE9) Moving Averages

Jul 22, 2024, 10:35 PM
Period
Simple
Exponential
MA5
247.20Buy
248.02Buy
MA10
243.44Buy
244.88Buy
MA20
239.69Buy
243.57Buy
MA50
251.39Buy
249.39Buy
MA100
261.58Sell
258.97Sell
MA200
271.31Sell
277.69Sell
Genmab A/S’s (GE9) 10-Day exponential moving average is 244.88, while Genmab A/S’s (GE9) share price is €253, making it a Buy.
Genmab A/S’s (GE9) 100-Day exponential moving average is 258.97, while Genmab A/S’s (GE9) share price is €253, making it a Sell.
Genmab A/S’s (GE9) stock price is €253 and Genmab A/S’s (GE9) 50-day simple moving average is 251.39, creating a Buy signal.
Genmab A/S’s (GE9) stock price is €253 and Genmab A/S’s (GE9) 100-day simple moving average is 261.58, creating a Sell signal.
Genmab A/S’s (GE9) stock price is €253 and Genmab A/S’s (GE9) 200-day simple moving average is 271.31, creating a Sell signal.

Genmab A/S (GE9) Technical Indicators

Jul 22, 2024, 10:35 PM
Name
Value
Implied Action
RSI (14)
59.93
Neutral
STOCH (9,6)
85.96
Sell
STOCHRSI (14)
89.29
Sell
MACD (12,26)
-0.15
Sell
ADX (14)
22.77
Neutral
Williams %R
0.00
-
CCI (14)
164.25
Sell
ATR (14)
5.33
-
Ultimate Oscillator
70.93
Buy
ROC
8.68
Buy
Genmab A/S’s (GE9) Relative Strength Index (RSI) is 59.93, creating a Neutral signal.
Genmab A/S’s (GE9) Trend Strength Indicator (ADX) is 22.77, creating a Neutral signal.
Genmab A/S’s (GE9) Commodity Channel Index (CCI) is 164.25, creating a Sell signal.
Genmab A/S’s (GE9) Price Rate of Change (ROC) is 8.68, creating a Buy signal.

FAQ

Is GE9 a Buy, Hold, or Sell?
Based on GE9’s technical indicators, GE9 is a Buy.
    What is GE9’s RSI (14)?
    GE9’s RSI (14) is 59.93, which suggests GE9 is a Neutral.
      What is GE9’s MACD?
      GE9’s MACD is -0.15, which suggests GE9 is a Sell.
        What is GE9’s 5-day moving average?
        GE9’s 5-day moving average is 247.20, which suggests GE9 is a Buy.
          What is GE9’s 20-day moving average?
          GE9 20-day moving average is 239.69, which suggests GE9 is a Buy.
            What is GE9’s 50-day moving average?
            GE9’s 50-day moving average is 251.39, which suggests GE9 is a Buy.
              What is GE9’s 200-day moving average?
              GE9’s 200-day moving average is 271.31, which suggests GE9 is a Sell.
                What is GE9’s Williams % R (14)?
                Currently, no data Available
                What is GE9’s CCI (14)?
                GE9’s CCI (14) is 164.25, which suggests GE9 is a Sell.
                  What is the share price of Genmab A/S?
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis